Innovations in Point of Care Diagnostics Market Set to Transform Patient Care"

The global point of care diagnostics market size is expected to be valued at USD 30.02 billion in 2024 and reach USD 47.82 billion by 2029, growing at a CAGR of 9.76 % from 2024 to 2029.

Point-of-care testing, also known as near-patient testing, is defined as medical diagnostic testing at or near the point of care-that is, at the time and place of patient care. The sample does not need to be sent to the laboratory for analysis, as the device or kit produces rapid and reliable results.

Global Point of Care Diagnostics Market Report Scope:

• Market Size (2029): USD 47.82 Billion
• Market Size (2024): USD 30.02 Billion
• CAGR (2024 to 2029): 9.76 %
• Base Year: 2023
• Forecast Period: 2024 to 2029
• Segments Analysed: Product, End-User, and Region.
• Geographies Covered: North America, Europe, APAC, Latin America, and Middle East & Africa.
• Key Market Players Profiled Abbott Laboratories, Inc., Danaher Corporation, Roche Diagnostics Limited, BioMerieux, Siemens Healthcare, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., and PTS Diagnostics Are playing a dominant role in the global point of care diagnostics market.

The demand for point-of-care diagnostic products is increasing due to the rising prevalence of acute and chronic infectious diseases worldwide, contributing to global market expansion. According to an article released jointly by WHO and the World Hepatitis Alliance, around 350 million people live with viral hepatitis worldwide, and chronic hepatitis B and C are the leading causes of liver cancer. Due to increasing cases of hepatitis, several programs have initiated the use of point-of-care tests to diagnose Hepatitis B and C viruses. For Instance, In November 2022, the Commonwealth Department of Health funded Flinders University International Centre for Point-of-care testing and Kirby Institute at UNSW for establishing the National Australian Hepatitis C Point-of-care testing program. These types of government initiatives create awareness among the people regarding diseases and their diagnoses, which enhances the adoption of point-of-care diagnostics by raising the market value. The increasing geriatric population with chronic diseases like high blood pressure and diabetes is demanding frequent glucose monitoring. These point-of-care devices include glucose monitoring kits, pregnancy, and fertility testing kits, infectious diseases testing kits, hematology testing kits, and others, which are in high demand by patients and healthcare professionals due to their rapid and reliable results, boosting the market growth. The growing demand for point-of-care diagnostic products in hospitals, clinics, and homes fuels the global market expansion. The rising investments in healthcare facilities, growing healthcare expenditure, technological advancements, and rising R&D investments are accelerating the adoption rate and driving the surge in market expansion.

The high costs associated with the technologies used in virus diagnostics limit the adoption of point-of-care diagnostics by restraining the market revenue. Another factor is frequent pre-analytical errors in point-of-care testing, which is estimated to restrict the new product launches by hampering the market growth. Additionally, the need for more accuracy in rapid results of a few point-of-care diagnostic tests limits the FDA approvals, which restricts the global market expansion. The presence of stringent regulatory requirements, which are complex and time-consuming, and the need for standardization hinder the growth of the global market by reducing the adoption rate.

Browse full details of the report @ https://www.marketdataforecast.com/market-reports/point-of-care-diagnostics-market

Key Insights from The Report:
• By Product, the glucose monitoring segment led the market and accounted for the largest share of the global market in 2023.
• Based on End- User, the clinic segment captured highest share of the global market in 2023.
• North America dominated the point of care diagnostics market in 2023. Europe accounted for second-highest share of the global market in 2023 and on the other hand, the Asia-Pacific region is estimated to grow at the fastest CAGR during the forecast period.
• Abbott Laboratories, Inc., Danaher Corporation, Roche Diagnostics Limited, BioMerieux, Siemens Healthcare, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., and PTS Diagnostics are dominated the point of care diagnostics market.

SEGMENTATION INCLUDED IN THIS REPORT:

By Product:
• Infectious Diseases
• Cardiac Markers
• Oncology Markers
• OTC Diagnostic Tests
• Drugs Of Abuse
• Blood Gas Testing
• Fertility Testing
• Urinalysis
• Coagulation
• Hematology
• Glucose Monitoring
• Ambulatory Chemistry
• Decentralized Clinical Chemistry
By End-User:
• Clinics
• Hospitals
• Home Healthcare
• Ambulatory Care Settings
• Laboratories
By Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Browse Regional Reports:
North America Point of Care (POC) Diagnostics/Testing Market Research Report - Segmented By Product, End-User & Country (United States, Canada, Mexico & Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/north-america-point-of-care-diagnostics-market
Europe Point of Care (POC) Diagnostics/Testing Market Research Report - Segmented By Product, End-User & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/europe-point-of-care-diagnostics-market
Asia-Pacific Point of Care (POC) Diagnostics/Testing Market Research Report - Segmented By Product, End-User & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Trends & Growth Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/asia-pacific-point-of-care-diagnostics-market

Latin America Point of Care (POC) Diagnostics/Testing Market Research Report - Segmented By Product, End-User & Country (Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/latin-america-point-of-care-diagnostics-market
Middle East & Africa Point of Care (POC) Diagnostics/Testing Market Research Report - Segmented By Product, End-User & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/middle-east-and-africa-point-of-care-diagnostics-market

TABLE OF CONTENTS:

1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Infectious Diseases
5.1.3 Cardiac Markers
5.1.4 Oncology Markers
5.1.5 OTC Diagnostic Tests
5.1.6 Drugs Of Abuse
5.1.7 Blood Gas Testing
5.1.8 Fertility Testing
5.1.9 Urinalysis
5.1.10 Coagulation
5.1.11 Hematology
5.1.12 Glucose Monitoring
5.1.13 Ambulatory Chemistry
5.1.14 Decentralized Clinical Chemistry
5.1.15 Others
5.1.16 Y-o-Y Growth Analysis, By Product
5.1.17 Market Attractiveness Analysis, By Product
5.1.18 Market Share Analysis, By Product
5.2 End-Users
5.2.1 Introduction
5.2.2 Clinics
5.2.3 Hospitals
5.2.4 Home Healthcare
5.2.5 Ambulatory Care Settings
5.2.6 Laboratories
5.2.7 Others
5.2.8 Y-o-Y Growth Analysis, By End-Users
5.2.9 Market Attractiveness Analysis, By End-Users
5.2.10 Market Share Analysis, By End-Users
5.3 Mode of Delivery
5.3.1 Introduction
5.3.2 OTC
5.3.3 Prescription
5.3.4 Y-o-Y Growth Analysis, By Mode of Delivery
5.3.5 Market Attractiveness Analysis, By Mode of Delivery
5.3.6 Market Share Analysis, By Mode of Delivery
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.4 Market Attractiveness Analysis
6.1.5 Market Share Analysis
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 the U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter's Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Abbott Laboratories
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Danaher Corporation
8.3 Roche Diagnostics
8.4 BioMerieux
8.5 Siemens Healthcare
8.6 Beckman Coulter
8.7 Becton Dickinson and Company
8.8 Johnson & Johnson
8.9 Johnson & Johnson
8.10 PTS Diagnostics
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures

Contact Us:
Market Data Forecast
www.marketdataforecast.com
Phone: +1-888-702-9626
Email: sales@marketdataforecast.com
5th Floor, Trendz Pride, Patrika Nagar Rd Number 1, HUDA Techno Enclave, HITEC City, Hyderabad, Telangana 500081, India

Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

This release was published on openPR.